目次
Chapter- 1: Introduction
Study Goals and Objectives
Scope of Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Oncology Pharmaceuticals, by Type, Through 2026
Figure Summary : Global Market for Oncology Pharmaceuticals, by Type, 2020-2026
Chapter- 3: Biology of Cancer
Overview
Stages of Cancer
Cancer Metastases
Drug Resistance
Treatment Approaches to Cancer
Non-pharmaceutical Approaches
Pharmacological Therapies
Personalized Cancer Therapy (Precision Medicine)
Chapter- 4: Market Breakdown by Drug Type
Overview
Chemotherapy
Hormone Therapy
Targeted Therapy
Immunotherapy
Global Market for Oncology Pharmaceuticals by Drug Type
Global Market for Targeted Therapy Pharmaceuticals by Drug Type
Global Market for Immunotherapy Pharmaceuticals by Drug Type
Global Market for Chemotherapy Pharmaceuticals
Global Market for Hormone Therapy Pharmaceuticals
Chapter- 5: Market Breakdown by Application
Overview
Lung Cancer
Breast Cancer
Multiple Myeloma
Prostate Cancer
Non-Hodgkin's Lymphoma
Colorectal Cancer
Other Cancers
Global Market for Oncology Pharmaceuticals by Cancer Type
Chapter- 6: Market Breakdown by Region
Global Markets for Oncology Pharmaceuticals by Region
North America
Europe
Asia-Pacific
RoW
Chapter- 7: Competitive Landscape
Overview
Blockbuster Oncology Pharmaceutical Brands
Key Oncology Pharmaceutical Brands
Hormone Therapy
Targeted Therapy
Immunotherapy
Global Market Shares of Leading Companies
Recent Industry Activities
Chapter- 8: New Developments and Pipeline Analysis
New Developments
Novel Oncology Drug Approvals
Biosimilar Approvals
Pipeline Analysis
Chapter- 9: Market Dynamics
Overview
Market Trends and Growth Drivers
Challenges
Chapter- 10: Impact of COVID-19 Pandemic
Implications on Cancer Diagnosis
Implications on Cancer Treatment
Impact on Oncology Pharmaceuticals Market
Chapter- 11: Company Profiles
ABBVIE INC.
AMGEN INC.
ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BAYER AG
BRISTOL-MYERS SQUIBB
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
JOHNSON & JOHNSON
MERCK & CO.
NOVARTIS AG
PFIZER INC.
SANOFI-AVENTIS
TAKEDA PHARMACEUTICAL CO. LTD.
Chapter- 12: Appendix: Acronyms
Table 74 : Acronyms Used in This Report
